Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Insulin (from the Latin, insula meaning island) is a peptide hormone produced by beta cells of the pancreatic islets. It regulates the metabolism of carbohydrates, fats and protein by promoting the absorption of, especially, glucose from the blood into fat, liver and skeletal muscle cells.In these tissues the absorbed glucose is converted into either glycogen via glycogenesis or fats (triglycerides) via lipogenesis, or, in the case of the liver, into both.Glucose production (and excretion into the blood) by the liver is strongly inhibited by high concentrations of insulin in the blood.Circulating insulin also affects the synthesis of proteins in a wide variety of tissues. It is therefore an anabolic hormone, promoting the conversion of small molecules in the blood into large molecules inside the cells. Low insulin levels in the blood have the opposite effect by promoting widespread catabolism.
This report elaborates on the current development of the Insulin industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
United Laboratories (TUL)
Shihuida PHARMA Group
Dongbao
Gan & Lee
Boehringer Ingelheim
Eli Lilly
Takeda Pharmaceutical Company
Emisphere
Henan Tian Fang Pharmaceutical
MannKind
GEA
Bioton
Sanofi
Bristol-Myers Squibb
Merck
Novartis
By Type:
Short-acting insulin
In effect insulin
Long-acting insulin
Ultra-short-acting insulin
By Application:
Type 2 diabetes
Others diabetes
Type 1 diabetes
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Insulin Market Overview 2018-2029
-
1.1 China Insulin Industry Development Overview
-
1.2 China Insulin Industry Development History
-
1.3 China Insulin Industry Market Size (2018-2029)
-
1.4 China Insulin Market Analysis by Type from Production Side
-
1.4.1 China Insulin Production Volume, Production Value and Growth Rate of Short-acting insulin (2018-2029)
-
1.4.2 China Insulin Production Volume, Production Value and Growth Rate of In effect insulin (2018-2029)
-
1.4.3 China Insulin Production Volume, Production Value and Growth Rate of Long-acting insulin (2018-2029)
-
1.4.4 China Insulin Production Volume, Production Value and Growth Rate of Ultra-short-acting insulin (2018-2029)
-
1.5 China Insulin Market Analysis by Application from Consumption End
-
1.5.1 China Insulin Sales Volume, Sales Value and Growth Rate of Type 2 diabetes (2018-2029)
-
1.5.2 China Insulin Sales Volume, Sales Value and Growth Rate of Others diabetes (2018-2029)
-
1.5.3 China Insulin Sales Volume, Sales Value and Growth Rate of Type 1 diabetes (2018-2029)
-
1.6 China Insulin Market Analysis by Region
-
1.6.1 North China Insulin Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Insulin Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Insulin Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Insulin Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Insulin Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Insulin Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Insulin Market Size and Growth Rate from 2018-2029
Chapter 2 China Insulin Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Insulin Market Status and Competition at home and abroad in 2023
-
2.2.2 China Insulin Market Status and Competition Analysis in 2023
-
2.2.3 China Insulin Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Insulin Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Insulin Industry Development
Chapter 3 InsulinIndustry Chain Analysis
-
3.1 Insulin Industry Chain
-
3.2 Insulin Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Insulin Market
-
3.3 Insulin Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Insulin Market
Chapter 4 China Insulin Market, by Type
-
4.1 China Insulin Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Insulin Total Production Volume and Growth Rate from Production Side
-
4.5 China Insulin Production Volume and Growth Rate, by Type
-
4.5.1 China Insulin Production Volume and Growth Rate of Short-acting insulin
-
4.5.2 China Insulin Production Volume and Growth Rate of In effect insulin
-
4.5.3 China Insulin Production Volume and Growth Rate of Long-acting insulin
-
4.5.4 China Insulin Production Volume and Growth Rate of Ultra-short-acting insulin
Chapter 5 China Insulin Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Insulin Total Market Size and Growth Rate from Consumption End
-
5.5 China Insulin Market Size and Growth Rate, by Application
-
5.5.1 China Insulin Market Size and Growth Rate of Type 2 diabetes
-
5.5.2 China Insulin Market Size and Growth Rate of Others diabetes
-
5.5.3 China Insulin Market Size and Growth Rate of Type 1 diabetes
Chapter 6 China Insulin Market, by Region
-
6.1 China Insulin Production Volume and Production Value, by Region
-
6.2 China Insulin Sales Volume and Sales Value, by Region
Chapter 7 North China Insulin Market Analysis
-
7.1 North China Insulin Market, by Type
-
7.2 North China Insulin Market, by Application
Chapter 8 Central China Insulin Market Analysis
-
8.1 Central China Insulin Market, by Type
-
8.2 Central China Insulin Market, by Application
Chapter 9 South China Insulin Market Analysis
-
9.1 South China Insulin Market, by Type
-
9.2 South China Insulin Market, by Application
Chapter 10 East China Insulin Market Analysis
-
10.1 East China Insulin Market, by Type
-
10.2 East China Insulin Market, by Application
Chapter 11 Northeast China Insulin Market Analysis
-
11.1 Northeast China Insulin Market, by Type
-
11.2 Northeast China Insulin Market, by Application
Chapter 12 Southwest China Insulin Market Analysis
-
12.1 Southwest China Insulin Market, by Type
-
12.2 Southwest China Insulin Market, by Application
Chapter 13 Northwest China Insulin Market Analysis
-
13.1 Northwest China Insulin Market, by Type
-
13.2 Northwest China Insulin Market, by Application
Chapter 14 Company Profiles
-
14.1 United Laboratories (TUL)
-
14.1.1 United Laboratories (TUL) Company Profile
-
14.1.2 United Laboratories (TUL) Insulin Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Shihuida PHARMA Group
-
14.2.1 Shihuida PHARMA Group Company Profile
-
14.2.2 Shihuida PHARMA Group Insulin Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Dongbao
-
14.3.1 Dongbao Company Profile
-
14.3.2 Dongbao Insulin Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Gan & Lee
-
14.4.1 Gan & Lee Company Profile
-
14.4.2 Gan & Lee Insulin Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Profile
-
14.5.2 Boehringer Ingelheim Insulin Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Profile
-
14.6.2 Eli Lilly Insulin Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Takeda Pharmaceutical Company
-
14.7.1 Takeda Pharmaceutical Company Company Profile
-
14.7.2 Takeda Pharmaceutical Company Insulin Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Emisphere
-
14.8.1 Emisphere Company Profile
-
14.8.2 Emisphere Insulin Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Henan Tian Fang Pharmaceutical
-
14.9.1 Henan Tian Fang Pharmaceutical Company Profile
-
14.9.2 Henan Tian Fang Pharmaceutical Insulin Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 MannKind
-
14.10.1 MannKind Company Profile
-
14.10.2 MannKind Insulin Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 GEA
-
14.11.1 GEA Company Profile
-
14.11.2 GEA Insulin Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Bioton
-
14.12.1 Bioton Company Profile
-
14.12.2 Bioton Insulin Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Sanofi
-
14.13.1 Sanofi Company Profile
-
14.13.2 Sanofi Insulin Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Bristol-Myers Squibb
-
14.14.1 Bristol-Myers Squibb Company Profile
-
14.14.2 Bristol-Myers Squibb Insulin Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Merck
-
14.15.1 Merck Company Profile
-
14.15.2 Merck Insulin Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Novartis
-
14.16.1 Novartis Company Profile
-
14.16.2 Novartis Insulin Market Performance
-
14.16.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Insulin Industry Research Conclusions
-
15.2 Insulin Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Insulin Industry Market Size (2018-2029)
-
Figure China Insulin Production Volume, Production Value and Growth Rate of Short-acting insulin (2018-2029)
-
Figure China Insulin Production Volume, Production Value and Growth Rate of In effect insulin (2018-2029)
-
Figure China Insulin Production Volume, Production Value and Growth Rate of Long-acting insulin (2018-2029)
-
Figure China Insulin Production Volume, Production Value and Growth Rate of Ultra-short-acting insulin (2018-2029)
-
Figure China Insulin Sales Volume, Sales Value and Growth Rate of Type 2 diabetes (2018-2029)
-
Figure China Insulin Sales Volume, Sales Value and Growth Rate of Others diabetes (2018-2029)
-
Figure China Insulin Sales Volume, Sales Value and Growth Rate of Type 1 diabetes (2018-2029)
-
Figure North China Insulin Market Size and Growth Rate from 2018-2029
-
Figure Central China Insulin Market Size and Growth Rate from 2018-2029
-
Figure South China Insulin Market Size and Growth Rate from 2018-2029
-
Figure East China Insulin Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Insulin Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Insulin Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Insulin Market Size and Growth Rate from 2018-2029
-
Figure Insulin Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Insulin Market Share by Type in 2018
-
Figure China Insulin Market Share by Type in 2023
-
Figure China Insulin Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Insulin Production Volume and Growth Rate of Short-acting insulin (2018-2023)
-
Figure China Insulin Production Volume and Growth Rate of In effect insulin (2018-2023)
-
Figure China Insulin Production Volume and Growth Rate of Long-acting insulin (2018-2023)
-
Figure China Insulin Production Volume and Growth Rate of Ultra-short-acting insulin (2018-2023)
-
Figure China Insulin Market Share by Application in 2018
-
Figure China Insulin Market Share by Application in 2023
-
Figure China Insulin Total Market Size and Growth Rate from Consumption End
-
Figure China Insulin Market Size and Growth Rate of Type 2 diabetes (2018-2023)
-
Figure China Insulin Market Size and Growth Rate of Others diabetes (2018-2023)
-
Figure China Insulin Market Size and Growth Rate of Type 1 diabetes (2018-2023)
-
Table China Insulin Production Volume by Region (2018-2023)
-
Table China Insulin Production Volume Share by Region (2018-2023)
-
Figure China Insulin Production Volume Share by Region (2018-2023)
-
Table China Insulin Production Value by Region (2018-2023)
-
Table China Insulin Production Value Share by Region (2018-2023)
-
Figure China Insulin Production Value Share by Region (2018-2023)
-
Table China Insulin Sales Volume by Region (2018-2023)
-
Table China Insulin Sales Volume Share by Region (2018-2023)
-
Figure China Insulin Sales Volume Share by Region (2018-2023)
-
Table China Insulin Sales Value by Region (2018-2023)
-
Table China Insulin Sales Value Share by Region (2018-2023)
-
Figure China Insulin Sales Value Share by Region (2018-2023)
-
Table North China Insulin Production Volume by Type (2018-2023)
-
Table North China Insulin Production Volume Share by Type (2018-2023)
-
Figure North China Insulin Production Volume Share by Type (2018-2023)
-
Table North China Insulin Sales Volume by Application (2018-2023)
-
Table North China Insulin Sales Volume Share by Application (2018-2023)
-
Figure North China Insulin Sales Volume Share by Application (2018-2023)
-
Table Central China Insulin Production Volume by Type (2018-2023)
-
Table Central China Insulin Production Volume Share by Type (2018-2023)
-
Figure Central China Insulin Production Volume Share by Type (2018-2023)
-
Table Central China Insulin Sales Volume by Application (2018-2023)
-
Table Central China Insulin Sales Volume Share by Application (2018-2023)
-
Figure Central China Insulin Sales Volume Share by Application (2018-2023)
-
Table South China Insulin Production Volume by Type (2018-2023)
-
Table South China Insulin Production Volume Share by Type (2018-2023)
-
Figure South China Insulin Production Volume Share by Type (2018-2023)
-
Table South China Insulin Sales Volume by Application (2018-2023)
-
Table South China Insulin Sales Volume Share by Application (2018-2023)
-
Figure South China Insulin Sales Volume Share by Application (2018-2023)
-
Table East China Insulin Production Volume by Type (2018-2023)
-
Table East China Insulin Production Volume Share by Type (2018-2023)
-
Figure East China Insulin Production Volume Share by Type (2018-2023)
-
Table East China Insulin Sales Volume by Application (2018-2023)
-
Table East China Insulin Sales Volume Share by Application (2018-2023)
-
Figure East China Insulin Sales Volume Share by Application (2018-2023)
-
Table Northeast China Insulin Production Volume by Type (2018-2023)
-
Table Northeast China Insulin Production Volume Share by Type (2018-2023)
-
Figure Northeast China Insulin Production Volume Share by Type (2018-2023)
-
Table Northeast China Insulin Sales Volume by Application (2018-2023)
-
Table Northeast China Insulin Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Insulin Sales Volume Share by Application (2018-2023)
-
Table Southwest China Insulin Production Volume by Type (2018-2023)
-
Table Southwest China Insulin Production Volume Share by Type (2018-2023)
-
Figure Southwest China Insulin Production Volume Share by Type (2018-2023)
-
Table Southwest China Insulin Sales Volume by Application (2018-2023)
-
Table Southwest China Insulin Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Insulin Sales Volume Share by Application (2018-2023)
-
Table Northwest China Insulin Production Volume by Type (2018-2023)
-
Table Northwest China Insulin Production Volume Share by Type (2018-2023)
-
Figure Northwest China Insulin Production Volume Share by Type (2018-2023)
-
Table Northwest China Insulin Sales Volume by Application (2018-2023)
-
Table Northwest China Insulin Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Insulin Sales Volume Share by Application (2018-2023)
-
Table United Laboratories (TUL) Company Profile
-
Table United Laboratories (TUL) Insulin Revenue, Price and Gross (2018-2023)
-
Table Shihuida PHARMA Group Company Profile
-
Table Shihuida PHARMA Group Insulin Revenue, Price and Gross (2018-2023)
-
Table Dongbao Company Profile
-
Table Dongbao Insulin Revenue, Price and Gross (2018-2023)
-
Table Gan & Lee Company Profile
-
Table Gan & Lee Insulin Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Insulin Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Insulin Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceutical Company Company Profile
-
Table Takeda Pharmaceutical Company Insulin Revenue, Price and Gross (2018-2023)
-
Table Emisphere Company Profile
-
Table Emisphere Insulin Revenue, Price and Gross (2018-2023)
-
Table Henan Tian Fang Pharmaceutical Company Profile
-
Table Henan Tian Fang Pharmaceutical Insulin Revenue, Price and Gross (2018-2023)
-
Table MannKind Company Profile
-
Table MannKind Insulin Revenue, Price and Gross (2018-2023)
-
Table GEA Company Profile
-
Table GEA Insulin Revenue, Price and Gross (2018-2023)
-
Table Bioton Company Profile
-
Table Bioton Insulin Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Insulin Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Insulin Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Insulin Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Insulin Revenue, Price and Gross (2018-2023)
-
